Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

FORGOTTEN HISTORY: Obesity news topic - The Untold Story

BMI alternative for identifying obesity ‘could prevent misdiagnosis in millions’

Combining body mass index with other measurements and tests would lead to better care and outcomes, experts say

The Guardian - UK · 5h ago

More than 1 million Brits 'wrongly classified as obese under flawed BMI'

The framework both overestimates and underestimates how excess body fat affects health, researchers say

The Independent UK · 5h ago

For diabetes patients, stopping GLP-1 drugs linked to doubled risk of heart attack, stroke, death

People with type 2 diabetes who stopped GLP-1 treatment had twice the risk of heart attack, stroke or death than those who continued, according to a new study.

Euronews · 14h ago

From analysis to the latest developments in health,
read the most diverse news in one place.

Experimental Obesity Drug Survodutide Did Not Raise Heart Attack or Stroke Risk in 5,530-Patient Safety Trial

A large trial found that experimental obesity drug survodutide did not increase major cardiovascular risks, but it has not been shown to protect the heart and caused frequent digestive side effects.

Medical Daily · 18h ago

Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn

GLP-1 products such as Ozempic and Mounjaro spread but many in poorer countries struggle to get basic diabetes treatment

The Guardian - UK · Nov 10

The FDA Ordered GLP-1 Vision-Loss Warnings For Some Products. Shares of Eli Lilly and Novo Nordisk Were Unfazed.

The updated labeling covers Mounjaro, Zepbound, Ozempic and Wegovy.

International Business Times · Nov 10

Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDA

Eli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (US FDA).

The Economic Times · Nov 9

Read news from The Economist, FT, and more,
with one subscription

It is time the government treated hunger and obesity as two interlinked problems

Letter: The cabinet committee the MPs want should become the delivery arm of a statutory right to adequate food, writes Prof Kent Buse of the World Obesity Federation

The Guardian - UK · Nov 8

Hims Agrees to Stop Selling Compounded Lilly Obesity Drugs as Zepbound and Foundayo Join Platform

Hims will sell Lilly's Zepbound and Foundayo directly while ending compounded copies of the company's obesity drugs on its platform. Patients buying elsewhere still face quality and dosing risks.

Medical Daily · Nov 8

Why indoor cats gain weight so easily, and how to help yours

A cat that spends its whole life inside a two-bedroom flat is safe, warm, and almost certainly eating more than it burns. Weight gain in indoor cats is not a mystery of metabolism. It is a straightforward arithmetic problem made easier by every comfort a flat provides. What flat life…

Times Pets · Nov 8

Cancer Survivors With Obesity and High Genetic Weight Scores Faced 82% Higher Risk of a Second Obesity-Related Cancer

A study of 14,309 cancer survivors found that obesity and genetic predisposition to higher body weight were associated with an increased risk of a second obesity-related cancer.

Medical Daily · Nov 6

Why Does Blood Pressure Increase at Night?

You go to bed expecting your body to rest, but something unexpected may be happening inside it. Instead of falling, your blood pressure may remain high or even increase while you sleep. This is not always easy to notice because there may be no obvious symptoms. While blood pressure normally…

MyLifeXP · Nov 6

Teen Obesity Gap: 9 in 10 Eligible Teens Got Neither GLP-1 Drugs nor Surgery as Insurance Shaped Prescriptions

Un estudio en JAMA Pediatrics halló que el 90,4% de más de 1,4 millones de adolescentes elegibles no recibió cirugía bariátrica ni medicamentos GLP-1 entre 2017 y 2025.

Medical Daily · Nov 5

Nine in 10 Teens With Severe Obesity Got Neither GLP-1 Drugs nor Surgery Despite a 35-Fold Prescribing Rise

A study of more than 1.4 million U.S. adolescents found that 90.4% of those eligible for bariatric surgery received neither surgery nor a GLP-1 medication through 2025.

Medical Daily · Nov 4

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Nov 4

GLP-1 Drugs Tied to 31% Lower Diabetes Risk Than Metformin in 256,492 Adults With Prediabetes and Obesity

Adults with prediabetes and obesity who took GLP-1 drugs had lower risks of type 2 diabetes and cardiovascular events than metformin users, though the observational findings remain preliminary.

The Independent UK · Nov 4

Drug-free diabetes implant offers ‘promising’ future for patients, say scientists

A new device could be implanted into the human body to treat diabetes and obesity without the need for drugs or insulin

Times Pets · Nov 4

Feeding a senior dog: what needs to change in the bowl as your dog ages

Around the time a dog's muzzle starts going grey, its body is already running a different set of calculations than it did at two or three years old. Metabolism slows, muscle mass drops even in dogs that look fine, kidneys begin to work less efficiently, and joints that absorbed years…

The Independent UK · Nov 3

Why a growing number of younger Americans are having strokes

Some 140,000 Americans die from strokes annually in the US

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Nov 3

Boys in England more likely to be obese than girls, according to latest data

IN FULL

The Independent UK · Nov 3

England's childhood obesity crisis in numbers as 'deprivation gap' widens

Data also showed a gender divide, with girls in primary school more likely than boys to be a healthy weight

Medical Daily · Nov 3

Diet and Supervised Workouts Put 54% of Young Adults With Type 2 Diabetes in Remission Within 24 Weeks

In a randomized trial, 54% of adults ages 18 to 45 achieved type 2 diabetes remission after a very low-calorie diet and supervised exercise, compared with 4% receiving usual care.

Times Pets · Nov 3

Russian Blue cat: shy with strangers but deeply loyal at home

The Russian Blue does not warm up quickly, and it is not trying to. This is a breed built on caution, not fear, not damage, but a genuine preference for the familiar over the unknown. In an Indian flat where guests arrive often and the doorbell rings without warning, that…

Times Life · Nov 2

Arthritis in Old Dogs: How Floors, Weight and Ramps Affect Joint Health

Canine osteoarthritis is not a disease that arrives all at once. It is a slow erosion of cartilage, the dense connective tissue that cushions the ends of bones inside a joint, and by the time a dog starts limping visibly, that cartilage has usually been thinning for months or years.…

The Economic Times · Oct 31

Drug-free treatment for diabetes and obesity may become possible as scientists develop a wireless device that detects high blood sugar levels and removes excess sugar from bloodstream

Diabetes treatment news: A team of scientists from France and Switzerland developed a wireless electronic device to manage diabetes. This device removes excess glucose from the bloodstream, potentially providing a drug-free treatment option. In studies, the device effectively regulated glucose levels in diabetic mice while promoting fat usage for energy.…

Budget and the Bees · Oct 31

Dr. Now Became a Reality TV Favorite on “My 600-Lb Life” — What Is His Net Worth?

Dr. Younan Nowzaradan has become one of reality television’s most recognizable physicians, thanks to his straightforward approach on TLC’s “My 600-Lb Life.” Better known as Dr. Now, the Houston-based surgeon has spent decades helping patients struggling with severe obesity. His popularity has also raised questions about how much money he…

1 2 3 4 5

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

American Academy of Pediatrics

177 stories

HIMS

153 stories

American Heart Association

102 stories

American Cancer Society

79 stories

University of Leicester

Northwestern Medicine

38 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.